ライフサイエンスコーパス: autoimmune pancreatitis

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 nsus was reached on the issue of subtypes of autoimmune pancreatitis.

2 s and development of new therapies for human autoimmune pancreatitis.

3 istics, course, and therapeutic responses in autoimmune pancreatitis.

4 n the rat, which we have termed experimental autoimmune pancreatitis.

5 t amylase may play a role in pathogenesis of autoimmune pancreatitis (6) 2-(18F)-Fluro-2-deoxy-D-gluc

6 h obstructive jaundice (77%) associated with autoimmune pancreatitis (92%), increased serum IgG4 leve

7 Reviews of autoimmune pancreatitis, a newly described condition, pa

8 um immunoglobulin G4 (sIgG4) is a feature of autoimmune pancreatitis (AIP) and IgG4-associated cholan

9 To summarize the existing knowledge of autoimmune pancreatitis (AIP) and to review the progress

10 ted pancreatic bicarbonate concentrations in autoimmune pancreatitis (AIP) by restoring mislocalized

11 k trial of corticosteroids may differentiate autoimmune pancreatitis (AIP) from pancreatic cancer in

12 Autoimmune pancreatitis (AIP) has been divided into subt

13 Autoimmune pancreatitis (AIP) is a heterogeneous autoimm

14 Autoimmune pancreatitis (AIP) is a rare and underdiagnos

15 Autoimmune pancreatitis (AIP) is an increasingly recogni

16 Autoimmune pancreatitis (AIP) is the pancreatic manifest

17 Autoimmune pancreatitis (AIP) underlies 5%-11% of cases

18 tify current modalities for the diagnosis of autoimmune pancreatitis (AIP) with the objective of esta

19 Autoimmune pancreatitis (AIP), a recently defined diseas

20 is known about the pathogenic mechanisms of autoimmune pancreatitis (AIP), an increasingly recognize

21 m retrospective case series of patients with autoimmune pancreatitis (AIP), and follow-up periods hav

22 ith pancreatic cancer, chronic pancreatitis, autoimmune pancreatitis (AIP), and healthy controls (N).

23 treatment, and at follow-up in patients with autoimmune pancreatitis (AIP).

24 re part of a spectrum of disorders including autoimmune pancreatitis and inflammatory pseudotumor.

25 patients, which may indicate an overlap with autoimmune pancreatitis and possible responsiveness to s

26 e the degree of inflammation and fibrosis in autoimmune pancreatitis and to monitor response to stero

27 ciations with inflammatory bowel disease and autoimmune pancreatitis, and medical therapy are discuss

28 ids rapidly reduce symptoms in patients with autoimmune pancreatitis, and micronutrient therapy to co

29 inical diagnostic and therapeutic aspects of autoimmune pancreatitis; and information on feeding stra

30 Furthermore, the complexities of diagnosing autoimmune pancreatitis are being recognized.

31 rts outlining the complexity in diagnosis of autoimmune pancreatitis; emerging roles of endoscopic ul

32 The clinical description of autoimmune pancreatitis has led to the realization that

33 Clinical description and studies of autoimmune pancreatitis have led to the realization that

34 sed with primary sclerosing cholangitis have autoimmune pancreatitis in association with primary scle

35 st that gastric H. pylori infection triggers autoimmune pancreatitis in genetically predisposed indiv

36 Features that suggest autoimmune pancreatitis include focal or diffuse pancrea

37 tive descriptive evaluation of patients with autoimmune pancreatitis including dedicated radiology re

38 Autoimmune pancreatitis may belong to a multiorgan immun

39 sh patients with IgG4-associated cholangitis/autoimmune pancreatitis (n = 34) from those with primary

40 res of IgG4-RSD in these 4 patients included autoimmune pancreatitis, sclerosing cholangitis, lymphop

41 nfirms that in non-expert practice settings, autoimmune pancreatitis scoring systems with a focus on

42 pancreatic lesions of rats with experimental autoimmune pancreatitis were characterized histologicall

43 -82 years) with histopathologic diagnosis of autoimmune pancreatitis were examined.

44 ts with radiographic OR clinical features of autoimmune pancreatitis were initially identifiable (Mal

45 utility of published diagnostic criteria for autoimmune pancreatitis, when compared to the characteri

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。